Skip to main content

Towergate backers buy private medical broker Chase Templeton

doctor777

Nevada Investments, the investment vehicle set up by HPS Investment Partners and Madison Dearborn Partners will buy medical broker Chase Templeton from Palatine Private Equity.

The backers of Towergate and Ryan Direct said they will help Chase Templeton continue to add to the 75 acquisitions it has made since 2013. The value of the sale was not disclosed.

Chase Templeton

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

Show password
Hide password

Q&A: Sharon Bishop, PremFina

Sharon Bishop, CEO of PremFina, explains how the business has scaled from helping 15 brokers in 2021 to more than 200 today, leveraged technology to stay ahead of regulation, and set its sights on becoming the UK’s leading premium finance provider.

Tesco Law and the insurer legal services revolution that never was

Content Director's View: More than a decade ago many insurers could not wait to seize the opportunities afforded by a change in the law that allowed them to set up their own legal services arms. Jonathan Swift reflects on what happened next - and the prospect of a one-stop-shop claims provider in the future.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here